Allianz Asset Management
GTHX

Allianz Asset Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Allianz Asset Management’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-20,495
Closed -$236K – 1972
2020
Q3 		$236K Sell
20,495
-1,259
-6% -$20.8K ﹤0.01% 1763
2020
Q2 		$527K Sell
21,754
-13,740
-39% -$227K ﹤0.01% 2039
2020
Q1 		$391K Sell
35,494
-15,809
-31% -$295K ﹤0.01% 2143
2019
Q4 		$1.36M Sell
51,303
-16,710
-25% -$391K ﹤0.01% 2060
2019
Q3 		$1.68M Buy
68,013
+17,741
+35% +$559K ﹤0.01% 1904
2019
Q2 		$1.54M Buy
50,272
+14,866
+42% +$313K ﹤0.01% 1982
2019
Q1 		$588K Buy
35,406
+22,083
+166% +$419K ﹤0.01% 2269
2018
Q4 		$255K Buy
+13,323
New +$499K ﹤0.01% 2451

Other funds holding GTHX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Allianz Asset Management's GTHX Position: Q4 2020 in Review

Allianz Asset Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2020, closing a stake of 20,495 shares — an estimated $236K sold.

Allianz Asset Management first reported a position in GTHX in Q4 2018 and held it in 8 quarters. The position peaked at $1.68M in Q3 2019. 125 funds tracked by Wall St. Rank hold GTHX as of Q4 2020.

  • Allianz Asset Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Allianz Asset Management sold 20,495 G1 Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $236K.
  • Allianz Asset Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2018 and held it in 8 quarters.
  • Allianz Asset Management's G1 Therapeutics, Inc. Common Stock position peaked at $1.68M in Q3 2019.
  • 125 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2020.

Based on Allianz Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.